Prognostic impact of CD133 expression in gastric carcinoma

Sumiya Ishigami, Shinichi Ueno, Takaaki Arigami, Yasuto Uchikado, Tetsuro Setoyama, Hideo Arima, Yoshiaki Kita, Hiroshi Kurahara, Hiroshi Okumura, Masataka Matsumoto, Yuko Kijima, Shoji Natsugoe

研究成果: Article査読

55 被引用数 (Scopus)


Background and Aim: CD133 expression in cancer cells has been recognised as a putative cancer stem cell (CSC) marker in epithelial malignancies. CD133 expression was evaluated in gastric cancer and the clinical impact of CD133-positive gastric cancer was clarified. Patients and Methods: Ninety-seven gastric cancer patients who received curative gastrectomy were enrolled. CD133 expression in cancerous tissue was evaluated by immunohistochemistry. Results: CD133 expression positively correlated with tumour extension and the degree of nodal involvement. CD133 expression significantly affected patient postoperative outcome. Multivariate analysis revealed CD133 positivity as an independent prognostic factor superior to the depth of invasion and similar to nodal involvement in gastric cancer (p<0.05). Conclusion: Even slight CD133 expression in gastric cancer patients may be a useful prognostic marker via CSC. Further examination of CD133 with respect to CSC markers can enable prediction of the recurrence risk of gastric cancer.

ジャーナルAnticancer research
出版ステータスPublished - 01-06-2010

All Science Journal Classification (ASJC) codes

  • 腫瘍学
  • 癌研究


「Prognostic impact of CD133 expression in gastric carcinoma」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。